(Q30528616)

14 August 2017

4 references

25 April 2019

7 August 2019

28 September 2019

20 November 2019

1 reference

Botulinum toxin as treatment for focal dystonia: a systematic review of the pharmaco-therapeutic and pharmaco-economic value (English)

1 reference

14 August 2017

1 reference

25 April 2019

1 reference

25 April 2019

1 reference

7 August 2019

1 reference

28 September 2019

1 reference

20 November 2019

1 reference

1 reference

E Zoons

1

1 reference

14 August 2017

M G W Dijkgraaf

2

1 reference

14 August 2017

J M Dijk

3

1 reference

14 August 2017

I N van Schaik

4

1 reference

14 August 2017

M A Tijssen

5

1 reference

14 August 2017

3 May 2012

1 reference

14 August 2017

1 December 2012

4 references

25 April 2019

7 August 2019

28 September 2019

20 November 2019

5 references

14 August 2017

25 April 2019

7 August 2019

28 September 2019

20 November 2019

259

1 reference

14 August 2017

12

1 reference

14 August 2017

2519-2526

1 reference

https://scigraph.springernature.com/pub.10.1007/s00415-012-6510-x

14 August 2017

0 references

cites work

Surgical treatment of dystonia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3506193

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3506193

Systemic weakness after therapeutic injections of botulinum toxin a: a case series and review of the literature.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3506193

Deep brain stimulation for hyperkinetics disorders: dystonia, tardive dyskinesia, and tics

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3506193

Surgical treatment of dystonia

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3506193

How common is the most common adult movement disorder? Update on the worldwide prevalence of essential tremor

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3506193

Good research practices for measuring drug costs in cost-effectiveness analyses: an international perspective: the ISPOR Drug Cost Task Force report--Part VI.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3506193

Comparison of botulinum neurotoxin preparations for the treatment of cervical dystonia.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3506193

Botulinum toxin for writer's cramp: a randomised, placebo-controlled trial and 1-year follow-up

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3506193

Prevalence and incidence of Parkinson's disease in Europe

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3506193

Pearls and pitfalls in the therapeutic use of botulinum toxin

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3506193

What are the determinants of quality of life in people with cervical dystonia?

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3506193

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3506193

A prevalence study of primary dystonia in eight European countries

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3506193

Costs of treating dystonias and hemifacial spasm with botulinum toxin A.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3506193

Measuring health-related quality of life

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3506193

An evaluation of a brief health status measure in elderly veterans

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3506193

Double-blind controlled study of botulinum toxin in adductor spasmodic dysphonia.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3506193

A pharmacoeconomic evaluation of botulinum toxin in the treatment of spasmodic torticollis.

20 June 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6510-X

Botulinum toxin treatment in neurological practice: how much does it really cost? A prospective cost-effectiveness study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6510-X

Impact of cervical dystonia on quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6510-X

Effect of dystonia and botulinum toxin treatment on health-related quality of life.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6510-X

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6510-X

How common is the most common adult movement disorder? Update on the worldwide prevalence of essential tremor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6510-X

Working capacity and cervical dystonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6510-X

Effect of cervical dystonia on employment: A retrospective analysis of the ability of treatment to restore premorbid employment status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6510-X

Quality of life in patients with focal dystonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6510-X

Determinants and status of quality of life after long-term botulinum toxin therapy for cervical dystonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6510-X

Spasmodic dysphonia: onset, course, socioemotional effects, and treatment response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6510-X

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6510-X

Efficacy and safety of purified botulinum toxin type A (Dysport) for the treatment of benign essential blepharospasm: a randomized, placebo-controlled, phase II trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6510-X

Quality of life in patients with blepharospasm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-012-6510-X

Factors affecting the health-related quality of life of patients with cervical dystonia and the impact of botulinum toxin type A injections.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3506193

Measuring patient benefit from botulinum toxin in the treatment of dystonia. Feasibility of cost-utility analysis.

26 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3506193

Botulinum toxin for people with dystonia treated by an outreach nurse practitioner: a comparative study between a home and a clinic treatment service

26 November 2018

1 reference

12 December 2020

The impact of blepharospasm and cervical dystonia on health-related quality of life and depression

1 reference

12 December 2020

Prevalence of primary focal and segmental dystonia in Oslo

1 reference

12 December 2020

Botulinum toxin versus trihexyphenidyl in cervical dystonia: a prospective, randomized, double-blind controlled trial

1 reference

12 December 2020

Long‐term botulinum toxin treatment increases employment rate in patients with cervical dystonia

1 reference

12 December 2020

Double-blind, randomised, parallel group pilot study comparing two botulinum toxin type A products for the treatment of blepharospasm

1 reference

12 December 2020

10.1007/S00415-012-6510-X

Identifiers

DOI

1 reference

Dimensions Publication ID

14 August 2017

0 references

1 reference

14 August 2017

PubMed publication ID

22552527

1 reference